Merck and Broad Institute Announce CRISPR License Framework to Encourage Innovation
Thursday, July 18, 2019 | Merck, a leading science and technology company, and the Broad Institute of MIT and Harvard announced
Read More
Thursday, July 18, 2019 | Merck, a leading science and technology company, and the Broad Institute of MIT and Harvard announced
Read MoreWednesday, July 17, 2019 | DrugName: methylnaltrexone bromide Bausch Health Companies Inc. and Progenics Pharmaceuticals, announced that the U.S.
Read MoreThursday, July 18, 2019 GB Sciences, Inc., through its subsidiary, GBS Global Biopharma, Inc., has filed a novel patent application
Read MoreTuesday, July 16, 2019 | DrugName : COM-701 Compugen Ltd., a clinical-stage cancer immunotherapy company and leader in predictive target
Read MoreTuesday, July 16, 2019 | DrugName : Pliaglis Crescita Therapeutics Inc., a commercial dermatology company with a portfolio of non-prescription
Read More